Trieu Vuong (CIK 0001587074)

Latest company ownership

Shares held
23,652,913
Last filed at
Aug 27, 2024
Confidence Score
51.1
2025Q4
Confidence Score History
2020Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jul 10, 2025 Jul 10, 2025 Oncotelic Therapeutics, Inc. CEO Buy 55.0 +198,737 0.07% ✗ $993.7
Jan 29, 2025 Jan 31, 2025 Oncotelic Therapeutics, Inc. CEO Buy 60.0 +346,844 0.30% ✗ $9.7K
Nov 22, 2024 Nov 26, 2024 Oncotelic Therapeutics, Inc. CEO Buy 60.0 +298,499 0.26% ✗ $8.6K
Aug 23, 2024 Aug 27, 2024 Oncotelic Therapeutics, Inc. CEO Buy 61.3 +500,000 0.43% ✗ $10K
Jun 29, 2023 Jun 30, 2023 Oncotelic Therapeutics, Inc. CEO Buy 61.3 +500,000 0.43% ✗ $10.9K
Jun 16, 2023 Jun 20, 2023 Oncotelic Therapeutics, Inc. CEO Buy 55.0 +100,000 0.09% ✗ $2.6K
Jun 14, 2023 Jun 16, 2023 Oncotelic Therapeutics, Inc. CEO Buy 61.3 +400,000 0.35% ✗ $13K
May 26, 2023 May 31, 2023 Oncotelic Therapeutics, Inc. CEO Buy 55.0 +126,888 0.11% ✗ $4.3K
May 2, 2023 May 2, 2023 Oncotelic Therapeutics, Inc. CEO Buy 55.0 +100,000 0.09% ✗ $4.5K
Dec 6, 2022 Dec 7, 2022 Oncotelic Therapeutics, Inc. CEO Buy 55.0 +120,000 0.11% ✗ $6K
Nov 22, 2022 Nov 25, 2022 Oncotelic Therapeutics, Inc. CEO Buy 55.0 +70,000 0.06% ✗ $5.6K
Sep 26, 2022 Sep 28, 2022 Oncotelic Therapeutics, Inc. CEO Buy 47.5 +20,000 0.02% ✗ $1.4K
Aug 25, 2022 Aug 29, 2022 Oncotelic Therapeutics, Inc. CEO Buy 55.0 +80,000 0.07% ✗ $6.6K
Nov 19, 2020 Nov 23, 2020 Oncotelic Therapeutics, Inc. CEO Buy 60.0 +50,500 0.25% ✗ $9.6K
Mar 26, 2020 Mar 27, 2020 Oncotelic Therapeutics, Inc. CEO Buy 47.5 +3,000 0.02% ✗ $360